5 gaps in care we can close with collaboration

We’re partnering with life sciences companies to address gaps in care, one of the key steps in better managing population health and improving patient outcomes. It’s important to collaborate with all stakeholders – patients, providers, payers, life sciences and health IT companies – because that’s how we’ll succeed with value-based care.

How is Allscripts working with life sciences companies? Here are a few examples:

#1 – Are clinicians identifying enough patients who need clinical intervention? Allscripts has independently analyzed best-in-class guidelines that address gaps in care for certain therapeutic areas. Allscripts builds those guidelines into point-of-care alerts. Sponsored by life sciences companies, we are educating providers and practices about how to use the Allscripts alerts to close gaps in care for patients. We have partnerships in place to address rheumatoid arthritis, diabetes, asthma, vaccines, and other therapeutic areas. These programs will increase awareness of potential gaps in care so that the clinician can work efficiently to improve patient outcomes.

#2 – Do patients take their scripts to the pharmacy? About 30% of new prescriptions go unfilled. Clinicians can provide patients with patient-appropriate medication education at the point of prescribing. This education has the added benefit of serving as a reminder for patients to pick up their medications and helps physicians achieve credit for the Meaningful Use patient education measure, in addition to driving medication first-fill compliance.

#3 – Can patients afford their prescriptions? Clinicians receive an alert at the point of care if there are any coupon programs available for the medication they just prescribed. Clinicians can pass those savings along to the patient, which also increases the likelihood of first-fill compliance and adherence.

#4 – Will prior authorization (PA) delay access to medications for patients? Certain high-cost medications must be pre-authorized by a payer before a patient can receive them and PA requirements are growing every year. Today’s authorization process is often a lengthy, manual back-and-forth process among the doctor, payer, pharmacy and patient. According to Frost and Sullivan, about 70% of patients who encounter a manual paper-based PA do not receive the original prescription, and patients abandon about 40% of manual PAs. Our partnership with payers and life sciences companies enables physicians to obtain PA electronically, leading to faster patient access to medications and reduced rates of prescription abandonment.

#5 – Does the provider have relevant patient care information from other providers? Inclusion of the Payers Health Profile in the EHR will enable and expand the longitudinal view of a patient’s health record based on claims and other data aggregated by the payer from multiple providers.

These are just a few examples of how we’re helping clinicians close gaps in care. We have the largest network of providers using EHR technology and a large patient base through the FollowMyHealth® patient portal. Working with all stakeholders, we’ll enable clinicians to access the knowledge they need to transform health care as we know it.

To learn more about our Payer and Life Sciences partnerships, visit our website or contact us.

Tags: ,

About the author

Faisal Mushtaq is President of Allscripts Payer Life Sciences business. This business focuses on generating immediate value for providers and patients by leveraging Allscripts data and clinical, adherence and education messaging infrastructure to enable improved clinical outcomes at a lower cost. Faisal leads a team of cross-functional professionals skilled in field sales, product management, and client support and implementation services. He also oversees the PayerPath business. Faisal has been in the healthcare IT industry since 2000 and has extensive entrepreneurial business experience. He has led teams of all sizes, spanning many organizational areas including Portfolio Strategy, Sales, Business Development, Technology, Operations and Software Development. Before Allscripts, Faisal served in several leadership roles at Misys, which was acquired by Allscripts in 2008. Following the acquisition, Faisal served in various executive leadership roles in the Solutions Development organization of Allscripts, including the leader of Solutions Management for the ambulatory market and the leader of Portfolio Management. Faisal is a member of the Board of Directors at the Council for Entrepreneurial Development, an organization that helps entrepreneurs grow their business by connecting them to the network, knowledge and capital needed to start their company. Faisal earned a Bachelor of Science degree in Computer Science and Computer Engineering from the University of Wisconsin-Madison. He has also completed Advanced Management Program at Harvard Business School.


Your email address will not be published. Required fields are marked *